Showing 2,679 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Adherence

Copy of Hepatitis C Medication Adherence Is an Important Challenge, Study Shows

Editor's pick
Kaiser Daily Global Health Policy Report
13 October 2011
New & experimental hepatitis C treatment

Transgene Says 3 Patients in Hepatitis Trial Had Blood Disorders

Editor's pick
Bloomberg Business Week
12 October 2011
New & experimental hepatitis C treatment

Pharmasset again expands hepatitis C drug study

Editor's pick
Bloomberg BusinessWeek
11 October 2011
New & experimental hepatitis C treatment

Vertex's Hep C Drug Needs A Growth Injection

Editor's pick
The Street
11 October 2011
New & experimental HIV treatments

Boehringer signs away HIV rights to focus on hep C - InPharm

Editor's pick
InPharm
7 October 2011
New & experimental hepatitis C treatment

ICAAC: HCV Drug Telaprevir Shows No Problematic Interactions with Raltegravir

Editor's pick
HIVandhepatitis.com
6 October 2011
Pharmaceutical industry

Bristol-Myers Is Close To Completing A Groundbreaking Hepatitis C Treatment

Editor's pick
Business Insider
3 October 2011
New & experimental hepatitis C treatment

Vertex takes early rounds of hep C bout with Merck

Editor's pick
Reuters
3 October 2011
Hepatitis C symptoms & diagnosis

Hepatitis C in the U.S. May Be Underestimated by Over a Million

Editor's pick
AIDSMeds
30 September 2011
Hepatitis C treatment

Hepatitis C patients likely to falter in adherence to treatment regimen over time, Penn study shows

Editor's pick
Eurekalert Medicine & Health
29 September 2011
Hepatitis C treatment

Updated Hepatitis C Practice Guidelines Now Available from AASLD

Editor's pick
Market Watch (press release)
28 September 2011
New & experimental hepatitis C treatment

J&J's hep C drug Incivo approved in Europe

Editor's pick
InPharm
22 September 2011
Exposure to HIV through medical procedures

CDC Calls for Improved Transplant Screening

Editor's pick
Fox News
21 September 2011
New & experimental hepatitis C treatment

New anti-hepatitis C drug BMS-790052 does well in Phase IIa study

News
20 September 2011
Hepatitis B

Shark chemical 'a good antiviral'

Editor's pick
BBC Health
20 September 2011
Hepatitis C transmission & prevention

Hepatitis C is transmitted by unprotected sex between HIV-infected men: Ongoing epidemic in New York City in HIV-infected men

Editor's pick
Science Daily
15 September 2011
New & experimental hepatitis C treatment

Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and PSI-938 for All HCV Genotypes

Editor's pick
Pharmasset press release
14 September 2011
Hepatitis C treatment side-effects

Coffee consumption reduces side-effects in people on hepatitis C treatment

News
14 September 2011
Hepatitis C transmission & prevention

Breakthrough opens new avenues for hep C vaccine

Editor's pick
Science Daily
13 September 2011
Hepatitis & HIV

Unexplained liver enzyme increases in patients with HIV could be due to hepatitis E virus: screening recommended

News
8 September 2011
New & experimental hepatitis C treatment

Pharmasset Announces 91% SVR12 From the PROTON Trial in Subjects With Hepatitis C Genotype 1

Editor's pick
Pharmasset press release
7 September 2011
New & experimental hepatitis C treatment

Dramatic Changes in Hepatitis C Treatment Expected to Continue

Editor's pick
Xconomy
7 September 2011
Hepatitis B

Co-infection with hepatitis delta increases risk of death for patients with HIV and chronic hepatitis B

News
5 September 2011
New & experimental hepatitis C treatment

Vertex Scores Big With Hepatitis Drug

Editor's pick
Investorplace.com
1 September 2011